Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Immunol.

Sec. Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1537043

This article is part of the Research TopicRisk and Protective Factors in the Natural History of AutoimmunityView all 11 articles

Decreased cigarette smoking may partially explain the increased prevalence of antinuclear antibodies in the United States

Provisionally accepted
  • 1Public Health & Scientific Research, DLH, LLC, Bethesda, MD, United States
  • 2Division of Intramural Research, National Institute of Environmental Health Sciences (NIH), Durham, United States
  • 3University of Florida, Gainesville, Florida, United States
  • 4National Institutes of Health (NIH), Bethesda, Maryland, United States

The final, formatted version of the article will be published soon.

Introduction: Despite well-known harmful health effects of smoking, research supports an inverse association with some autoimmune diseases. High-titer antinuclear antibodies (ANA) are associated with autoimmune diseases, and ANA prevalence in the US increased between 1988 and 2012. Tobacco smoking decreased during those years while vaping of electronic cigarettes (e-cigarettes) increased after their introduction in 2007. Carbon monoxide (CO) may ameliorate autoimmunity, and e-cigarettes deliver much less CO than regular cigarettes. We explored interdependencies among ANA, smoking, and time. Methods: We analyzed cross-sectional data on ANA and the primary nicotine metabolite, cotinine, in 13,288 participants ≥12 years old from three time periods (1988-1991, 1999-2004, 2011-2012) of the US National Health and Nutrition Examination Survey. Smoking exposure (none, passive, active) was inferred from serum cotinine. We used logistic regression to analyze ANA prevalence, adjusted for sex, age, and race/ethnicity. Results: Over the study periods, ANA prevalence was highest (13.3-19.2%) for nonsmokers but non-trending; lower (11.1-15.5%) for "passive" smokers but steadily increasing; and even lower for active smokers but increasing from 7.4% in 1999-2004 to 13.3% in 2011-2012. The increases in ANA among passive and active smokers were mainly in adolescents (ages 12-19 years). Smokers had reduced odds of ANA in 1999-2004, with an odds ratio (OR) of 0.65 and a 95% confidence interval (CI) of 0.45-0.93, but this association was weaker in 1988-1991 (OR=0.80; 95% CI:0.52-1.22) and 2011-2012 (OR=0.82; 95% CI:0.56-1.21). Discussion: Although smoking causes harmful health effects, ANA data are consistent with it playing a role in decreasing autoimmunity. Recent vaping among adolescents may partially explain their large increase in ANA prevalence. The inverse ANA association with smoking strengthened between 1988-1991 and 1999-2004, but then weakened by 2011-2012. The initial strengthening was potentially because nonsmokers were exposed to progressively less CO (and/or other components of secondhand smoke), due to tightened smoking restrictions, while the potential nicotine-associated protection against ANA may have weakened after e-cigarettes became a source. Smoking should not be recommended given its negative health impacts. However, further studies could elucidate new mechanisms, perhaps involving components of tobacco smoke or vaping, possibly enabling development of novel preventative or treatment measures.

Keywords: Antinuclear antibodies (ANA), Autoimmune Diseases, carbon monoxide (CO), Cotinine, E-cigarettes, national Health and Nutrition Examination Survey (NHANES), tobacco smoking, vaping

Received: 29 Nov 2024; Accepted: 04 Aug 2025.

Copyright: © 2025 Dinse, Weinberg, Parks, Co, Priest, Chan and Miller. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Frederick William Miller, Division of Intramural Research, National Institute of Environmental Health Sciences (NIH), Durham, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.